Schumacher Chiropractic Clinics, P.A.
A Family of Chiropractic Care for over 30 years
Your Subtitle text
ScoliScore AIS Prognostic Test

Schumacher Chiropractic Clinics to administer ScoliScore™ AIS Prognostic Test, the first commercially available genetic test for a spine deformity

Schumacher Chiropractic Clinics, P.A. offers patients ScoliScore™ AIS Prognostic Testing - a new simple saliva test that may help doctors determine which children diagnosed with mild adolescent idiopathic scoliosis (AIS) are least likely to develop a painful and debilitating curvature of the spine is now available for the first time.

The ScoliScore™ Prognostic AIS Test, developed by Axial Biotech and distributed by DePuy Spine, uses the science of genetics to help doctors identify low risk patients, potentially saving them from years of repeated office visits and x-ray exposure, as well as the stress and anxiety associated with the uncertainty of scoliosis curve progression.

The researchers who developed the ScoliScore™ Test identified 53 DNA markers that are linked to the progressive form of scoliosis. The fewer of these genetic markers that are found in the saliva, the lower the score will be and the lower the risk of curve progression. Patients can get a score anywhere between 1 and 200 - 50 or less is considered low risk.

About 6 million people in the U.S. have scoliosis. Most of them are children between 10 and 15-years old. Fortunately, in most cases, scoliosis is mild or moderate and generally does not require surgical treatment. However, according to the American Academy of Orthopaedic Surgeons (AAOS), scoliosis progresses in one-in-four patients to a point that requires treatment including chiropractic care, physical therapy, back bracing and for some, spinal fusion surgery.

The ScoliScore™ Test is the first clinically validated and highly accurate genetic test for Adolescent Idiopathic Scoliosis (AIS) curve progression.

To administer the test, a saliva sample is collected in the doctors office at Schumacher Chiropractic Clinic and then sent to Axial Biotech for analysis. The confidential test results are typically available within a few weeks. Patients can get a score anywhere between 1 and 200 - 50 or less is considered low risk.

The ScoliScore™ Test is intended for self-reported Caucasian children between age 9 and 13 diagnosed with Mild (10-25 degree Cobb Angle) Adolescent Idiopathic Scoliosis (AIS). The ScoliScore™ Test results can help doctors understand the likelihood of curve progression, but does not identify which treatments to use. Test results should be used with other diagnostic information to help the patient and doctor determine the best course of action.

Video - Patient Stories

Watch Isabelle's Story

Are you having trouble viewing this video? click here for Help

Do you have questions about scoliosis screening or administering the ScoliScore™ AIS Prognostic Test? Please call us, we will be happy to assist you.

Schumacher Chiropractic Clinics, P.A.

 Click here Hopkins Clinic
8534 Excelsior Blvd
Hopkins, MN 55343

 Click here St Paul Clinic
1201 Payne Ave
St Paul, MN 55130

The SCOLISCORE AIS Prognostic Test was designed and validated by Axial Biotech, Inc. and is co-marketed and sold by both DePuy Spine, Inc. and Smith & Nephew, Inc.

Indications for Use: The SCOLISCORE™ AIS Prognostic Test is intended for in vitro use only. The SCOLISCORE Test is indicated for Caucasian, adolescent males and females between the ages of 9-13 years with a mild curve (Cobb angle 10-25°). This test utilizes DNA extracted from a saliva specimen in a polymerase chain reaction to detect the genotypes for genetic markers found in clinical trials to be associated with severe curve progression in patients diagnosed with Adolescent Idiopathic Scoliosis (AIS). Results from the SCOLISCORE Test are intended for use as an adjunct to existing clinical and radiologic information to determine the risk of curve progression. For additional information regarding indications for use, please see the SCOLISCORE Test package insert.

Caution: The SCOLISCORE™ Test is designed to accurately predict the likelihood of severe curve progression for patients diagnosed with Mild AIS and who received a SCOLISCORE in the Low Risk Classification (1- 50). Therefore, care should be exercised when utilizing the risk of progression for patients in the Intermediate Risk (51 � 179) and High Risk Classifications (180 � 200). The SCOLISCORE Test information should always be interpreted with all other clinical factors when determining the appropriate clinical treatment and care of patients. Under Federal law, this test may only be performed on the order of a physician and its results may only be reported to the ordering physician.